Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

20122,184 citationsJournal Article

Authors

Good health and well-being

Published in: The Lancet

Volume 380, Issue 9842, pp. 651-659

Field-Weighted Citation Impact: 65.60